Dynamic Effects of CYP2D6 Genetic Variants in a Set of Poor Metaboliser Patients with Infiltrating Ductal Cancer Under Treatment with Tamoxifen

Scientific Reports
Yeimy Viviana Ariza MárquezJuvenal Yosa Reyes

Abstract

Breast cancer is a group of multigenic diseases. It is the most common cancer diagnosed among women worldwide and is often treated with tamoxifen. Tamoxifen is catalysed by cytochrome P450 2D6 (CYP2D6), and inter-individual variations in the enzyme due to single nucleotide polymorphisms (SNPs) could alter enzyme activity. We evaluated SNPs in patients from Colombia in South America who were receiving tamoxifen treatment for breast cancer. Allelic diversity in the CYP2D6 gene was found in the studied population, with two patients displaying the poor-metaboliser phenotype. Molecular dynamics and trajectory analyses were performed for CYP2D6 from these two patients, comparing it with the common allelic form (CYP2D6*1). Although we found no significant structural change in the protein, its dynamics differ significantly from those of CYP2D6*1, the effect of such differential dynamics resulting in an inefficient enzyme with serious implications for tamoxifen-treated patients, increasing the risk of disease relapse and ineffective treatment.

References

Apr 11, 2001·Methods and Findings in Experimental and Clinical Pharmacology·C A IsazaR Cacabelos
Feb 27, 2003·The Breast Journal·Boo SvartboLars Age Johansson
Apr 22, 2004·Journal of Molecular Graphics & Modelling·Michael FeigCharles L Brooks
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Aug 31, 2006·Bioinformatics·Barry J GrantLeo S D Caves
Sep 1, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hyeong-Seok LimJungsil Ro
Sep 26, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V Craig Jordan, Bert W O'Malley
Jul 25, 2009·Nature Reviews. Cancer·Janelle M HoskinsHoward L McLeod
Oct 8, 2009·JAMA : the Journal of the American Medical Association·Werner SchrothHiltrud Brauch
Jan 9, 2010·Salud pública de México·Peggy L Porter
Jan 9, 2010·Salud pública de México·Rafael Lozano-AscencioLizbeth López-Carrillo
Jul 22, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Ahmedin JemalElizabeth M Ward
Mar 25, 2011·Clinical Pharmacology and Therapeutics·L MadlenskyJ P Pierce
Oct 15, 2011·Journal of Computational Chemistry·Kiumars ShahrokhThomas E Cheatham
Feb 7, 2012·The Journal of Biological Chemistry·An WangEric F Johnson
Aug 14, 2012·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Felicia M KnaulJulio Frenk
Oct 25, 2012·PLoS Computational Biology·Eva ChovancovaJiri Damborsky
Feb 28, 2013·The Oncologist·Nahila JustoEduardo Cazap
Mar 15, 2013·Clinical Pharmacology and Therapeutics·J K HicksUNKNOWN Clinical Pharmacogenetics Implementation Consortium
May 2, 2013·The Journal of Biological Chemistry·Eric F Johnson, C David Stout
Jun 20, 2013·International Journal of Medical Sciences·Mercedes Zafra-CeresCarolina Gomez-Llorente
Oct 9, 2013·Bulletin of the World Health Organization·Silvana LucianiVilma Gawryszewski
Apr 25, 2014·Journal of Medical Toxicology : Official Journal of the American College of Medical Toxicology·Suad A Al-AbriKent R Olson
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Oct 16, 2014·Expert Opinion on Drug Metabolism & Toxicology·Adrián LLerenaEduardo Tarazona-Santos
Jan 22, 2015·Salud pública de México·Luis Eduardo BravoJaime Rubiano
Jun 8, 2015·Breast Cancer Research and Treatment·Lisette BinkhorstRon H J Mathijssen
Nov 18, 2015·Journal of Chemical Theory and Computation·James A MaierCarlos Simmerling
Sep 8, 2009·Journal of Chemical Theory and Computation·M J Harvey, G De Fabritiis
May 12, 2016·Drug Metabolism Reviews·Pramod C NairJohn O Miners
Feb 17, 2017·Journal of Cancer Education : the Official Journal of the American Association for Cancer Education·Alejandra Hurtado-de-MendozaVanessa B Sheppard
Mar 9, 2018·Pharmacogenetics and Genomics·Rachel HuddartTeri E Klein
Apr 29, 2018·Current Treatment Options in Oncology·Irene E G van HellemondVivianne C G Tjan-Heijnen
Aug 22, 2018·Journal of Chemical Information and Modeling·André FischerMartin Smieško

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCA
PCR
X-ray

Software Mentioned

UCSF chimera
AMBER
PTRAJ
Bio3D
MMTSB
PMEMD engine
Amber14
QuantStudio
CAVER
CPPTRAJ

Related Concepts

Related Feeds

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Pharmaceuticals
Roberta Ferraldeschi, William G Newman
Clinical Advances in Hematology & Oncology : H&O
Cindy Gaston, Jill Kolesar
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Kostandinos SiderasMatthew P Goetz
Expert Review of Anticancer Therapy
Hitoshi ZembutsuYusuke Nakamura
© 2022 Meta ULC. All rights reserved